Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HW243040 in Healthy Participants
NCT07841522Phase 1Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Sep 2026
- Primary completion
- Jul 2027
01
Overview
Phase 1, randomised, double-blind trial of HW243040 in neuropathic pain (11 arms), sponsored by Third Xiangya Hospital, Central South University. Primary endpoints: Incidence of Treatment-Emergent Adverse Events, Number of Participants with Clinically Significant Vital Signs Changes and 2 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
HW243040
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT07841522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07841522.